The dose-response meta-analysis showed that higher doses of GLP-1 RAs were associated with increased risks of nausea, vomiting, diarrhea, constipation, and decreased appetite
[DOI] [PubMed] [Google Scholar] 75.Kaneko S., Ueda Y., Tahara Y
GLP-1 medications reduce hunger and slow digestion, so take note of which foods cause discomfort or nausea, especially as your dosage changes
Agarwal shares simple but transformative strategies like the 20-20-20 rule, visual breaks, and mindful movement to protect your eyes, brain, and emotional regulation
Novos closest rival is Eli Lilly, a far larger and more diversified healthcare giant
Differences in access, treatment persistence, and policyholder behavior, including lapse and re-entry patterns, could also introduce new forms of selection risk